• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Richard W. Troughton, C M Frampton, +14 authors Michael Gary Nicholls
  • Medicine
  • European heart journal
  • 2014 (First Published: 1 June 2014)
  • AIMS Natriuretic peptide-guided (NP-guided) treatment of heart failure has been tested against standard clinically guided care in multiple studies, but findings have been limited by study size. WeContinue Reading
  • Ravi V. Shah, Quynh A. Truong, Hanna Kim Gaggin, Jens Pfannkuche, Oliver Hartmann, James L Januzzi
  • Medicine
  • European heart journal
  • 2012 (First Published: 1 September 2012)
  • AIMS The aim of this study was to assess diagnostic and prognostic value of mid-regional pro-atrial natriuretic peptide (MR-proANP) and adrenomedullin (MR-proADM) for the evaluation of patientsContinue Reading
  • Hanna Kim Gaggin, Shweta R. Motiwala, Anju Bhardwaj, Kimberly A Parks, James L Januzzi
  • Medicine
  • Circulation. Heart failure
  • 2013 (First Published: 1 November 2013)
  • BACKGROUND Concentrations of soluble (s)ST2 predict prognosis in heart failure. We recently found changing doses of β-blocker (BB) may affect sST2 concentrations. It remains unclear whether sST2Continue Reading
  • Shweta R. Motiwala, Jackie Szymonifka, +6 authors James L Januzzi
  • Medicine
  • European journal of heart failure
  • 2013 (First Published: 1 October 2013)
  • AIMS Galectin-3 is a prognostic heart failure (HF) biomarker that may mediate cardiac fibrosis. We examined the value of serial galectin-3 measurement for prognosis and response to therapy in chronicContinue Reading
  • Hans‐Peter Brunner‐La Rocca, L. W. M. Eurlings, +14 authors Richard W. Troughton
  • Medicine
  • European journal of heart failure
  • 2015 (First Published: 1 December 2015)
  • AIMS Previous analyses suggest that heart failure (HF) therapy guided by (N-terminal pro-)brain natriuretic peptide (NT-proBNP) might be dependent on left ventricular ejection fraction, age andContinue Reading
  • Hanna Kim Gaggin, Quynh A. Truong, +13 authors James L Januzzi
  • Medicine
  • Congestive heart failure
  • 2013 (First Published: 1 May 2013)
  • Many proven heart failure (HF) therapies decrease N-terminal pro B-type natriuretic peptide (NT-proBNP) values over time, yet some patients have an NT-proBNP >1000 pg/mL following treatment, which isContinue Reading
  • Nasrien E. Ibrahim, James L Januzzi, +8 authors Roland R J van Kimmenade
  • Medicine
  • Journal of the American College of Cardiology
  • 2017 (First Published: 1 March 2017)
  • BACKGROUND Noninvasive models to predict the presence of coronary artery disease (CAD) may help reduce the societal burden of CAD. OBJECTIVES From a prospective registry of patients referred forContinue Reading
  • Rory B. Weiner, Aaron L Baggish, +11 authors James L Januzzi
  • Medicine
  • European journal of heart failure
  • 2013 (First Published: 1 March 2013)
  • AIMS We sought to determine if heart failure (HF) care with a goal to lower N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations, compared with standard of care (SOC) management, isContinue Reading